カテゴリ： GlobalData, アメリカ, 企業調査

Baxter International Inc (BAX)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Baxter International Inc (BAX) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7304
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：77
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Baxter International Inc (Baxter) is a provider of healthcare products, including dialysis in acute and chronic conditions, sterile intravenous solutions, parenteral nutrition therapies, generic injectable pharmaceuticals, infusion systems and devices, inhaled anesthetics, and surgical hemostat and sealant products. The company’s products find application in hospitals, kidney dialysis centers, rehabilitation centers, nursing homes and clinics, besides patients at home under physician supervision. Baxter distributes its products through direct sales force and also through a network of independent distributors, drug wholesalers, specialty pharmacies and other alternative site providers. The company has operations in the Americas, the Middle East, Africa, Europe and Asia-Pacific. Baxter is headquartered in Deerfield, Illinois, the US.

Baxter International Inc (BAX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Baxter International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Baxter International Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Baxter International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Baxter International Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Baxter International Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Baxter International Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Baxter International Acquires Two Hemostat and Sealant Products from Mallinckrodt 11
Private Equity 12
Third Point Acquires 7% Stake in Baxter International 12
Partnerships 13
Baxter International Enters into Licensing Agreement with Ramot 13
AWAK Technologies Enters Into Licensing Agreement With Baxter International For Dialysis Technology 14
Baxter International and Mayo Clinic Form Renal Care Center 15
Baxter International Enters into Partnership with University of Southern California 16
Rockwell Medical Enters into Distribution Agreement with Baxter Healthcare 17
Debt Offering 18
Baxter International Prices Public Offering of 1.3% Notes Due 2025 for USD668.2 Million 18
Baxter Completes Public Offering Of Notes Due 2018 For US$750 Million 20
Baxter Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 22
Baxter Completes Public Offering Of Notes Due 2014 For US$500 Million 24
Baxter Completes Public Offering Of Notes Due 2043 For US$500 Million 26
Baxter Completes Public Offering Of Notes Due 2016 For US$500 Million 28
Asset Transactions 30
Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter 30
Sunshine Heart Acquires Aquadex Product Line from Baxter 31
Nikkiso Completes Acquisition Of Continuous Renal Replacement Therapy Business Of Baxter International For US$38.8 Million 32
Acquisition 33
Baxter Completes Acquisition Of Gambro, Dialysis Products Maker, For US$4 Billion 33
Baxter International Acquires Remaining 60% Stake In Sigma International General Medical Apparatus For US$90 Million 35
Baxter International Completes Acquisition Of Synovis Life Technologies For US$325 Million 36
Baxter International Inc – Key Competitors 38
Baxter International Inc – Key Employees 39
Baxter International Inc – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Joint Venture 46
Recent Developments 48
Strategy And Business Planning 48
May 02, 2018: Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease 48
Financial Announcements 49
Jul 26, 2018: Baxter Reports Second-Quarter 2018 Results and IncreasesEarnings Outlook for Full-Year 2018 49
Apr 26, 2018: Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018 51
Feb 01, 2018: Baxter Reports 2017 Fourth-Quarter and Full-Year Results 53
Oct 25, 2017: Baxter Reports Third-Quarter 2017 Results and Updates Financial Outlook For Full-Year 2017 56
Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 58
Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017 60
Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 62
Corporate Communications 64
Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 64
Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 65
Product News 66
May 30, 2018: Baxter Unveiled Updates to SHARESOURCE Remote Patient Management Platform for Home Dialysis Patients at ERA-EDTA 2018 66
Jun 01, 2017: Baxter to Present Significant Data at ERA-EDTA 2017 to Help Advance New Standards of Renal Care 67
Other Significant Developments 68
Jun 28, 2018: Baxter Releases 2017 Corporate Responsibility Report and Reinforces Its Commitment to Enriching Communities Around the World 68
May 21, 2018: Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference 69
Nov 02, 2017: Baxter Supports 27 Abstract Presentations at ASN Kidney Week to Advance Scientific Exchange Focused on New Standards of Renal Care 71
Oct 12, 2017: Baxter Provides Update on Puerto Rico Recovery Status Post Hurricane Maria 72
Aug 31, 2017: Baxter and MATTER Healthcare Incubator Partner on Patient-Driven Innovation 74
Jul 06, 2017: Baxter, Ramot At Tel Aviv University And Tel Aviv Sourasky Medical Center partner to bring new surgical innovations worldwide 75
Jun 26, 2017: Baxter Announces DoseEdge Bi-Directional Integration with Epic in the Pharmacy 76
Appendix 77
Methodology 77
About GlobalData 77
Contact Us 77
Disclaimer 77

List of Tables
Baxter International Inc, Medical Equipment, Key Facts, 2017 2
Baxter International Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Baxter International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Baxter International Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Baxter International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Baxter International Inc, Deals By Market, 2012 to YTD 2018 9
Baxter International Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Baxter International Acquires Two Hemostat and Sealant Products from Mallinckrodt 11
Third Point Acquires 7% Stake in Baxter International 12
Baxter International Enters into Licensing Agreement with Ramot 13
AWAK Technologies Enters Into Licensing Agreement With Baxter International For Dialysis Technology 14
Baxter International and Mayo Clinic Form Renal Care Center 15
Baxter International Enters into Partnership with University of Southern California 16
Rockwell Medical Enters into Distribution Agreement with Baxter Healthcare 17
Baxter International Prices Public Offering of 1.3% Notes Due 2025 for USD668.2 Million 18
Baxter Completes Public Offering Of Notes Due 2018 For US$750 Million 20
Baxter Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 22
Baxter Completes Public Offering Of Notes Due 2014 For US$500 Million 24
Baxter Completes Public Offering Of Notes Due 2043 For US$500 Million 26
Baxter Completes Public Offering Of Notes Due 2016 For US$500 Million 28
Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter 30
Sunshine Heart Acquires Aquadex Product Line from Baxter 31
Nikkiso Completes Acquisition Of Continuous Renal Replacement Therapy Business Of Baxter International For US$38.8 Million 32
Baxter Completes Acquisition Of Gambro, Dialysis Products Maker, For US$4 Billion 33
Baxter International Acquires Remaining 60% Stake In Sigma International General Medical Apparatus For US$90 Million 35
Baxter International Completes Acquisition Of Synovis Life Technologies For US$325 Million 36
Baxter International Inc, Key Competitors 38
Baxter International Inc, Key Employees 39
Baxter International Inc, Subsidiaries 41
Baxter International Inc, Joint Venture 46

List of Figures
Baxter International Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Baxter International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Baxter International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Baxter International Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Baxter International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Baxter International Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Baxter International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Baxter International Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Baxter International Inc (BAX)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • 8point3 Energy Partners LP (CAFD)：電力：M&Aディール及び事業提携情報
    Summary 8point3 Energy Partners LP (8point3 Energy) is a renewable energy company that owns, operates and acquires solar energy generation projects. The company offers operation and maintenance, project development, and technical services. It operates residential, commercial, industrial, and utility …
  • WEC Energy Group：企業の戦略・SWOT・財務情報
    WEC Energy Group - Strategy, SWOT and Corporate Finance Report Summary WEC Energy Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Credit Mutuel-Cic Group：企業の戦略・SWOT・財務分析
    The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report Summary The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Vitro, S.A.B. de C.V.：企業の戦略・SWOT・財務情報
    Vitro, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Vitro, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Showa Shell Sekiyu KK (5002)：電力：M&Aディール及び事業提携情報
    Summary Showa Shell Sekiyu KK (Showa Shell) is an energy company. It mainly manufactures and sells oil products and energy related products, such as solar cell products and electricity. The company procures crude oil, refines, stores and sells petroleum products. Its product portfolio includes gasol …
  • Vestas Wind Systems AS (VWS)：電力：M&Aディール及び事業提携情報
    Summary Vestas Wind Systems A/S (Vestas) is a renewable energy company that designs, manufactures, constructs, installs, and services wind turbines. The company partners with customers to monitor wind energy production and performance of the wind power plant throughout its lifetime. It offers soluti …
  • Grupo Aeromexico SAB de CV：企業の財務・戦略的SWOT分析
    Grupo Aeromexico SAB de CV - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Chevron Corporation (CVX)-エネルギー分野：企業M&A・提携分析
    Summary Chevron Corporation (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and distribution of oil and gas products. Chevron explores for produces and transports cr …
  • Clinuvel Pharmaceuticals Ltd (CUV)：製薬・医療：M&Aディール及び事業提携情報
    Summary Clinuvel Pharmaceuticals Ltd (Clinuvel Pharmaceuticals) is a biopharmaceutical company which focuses on the development of drugs for the treatment of severe skin disorders. Its lead product candidate, Scenesse (afamelanotide) is a first-in-class drug targeting erythropoietic protoporphyria ( …
  • Hasbro, Inc. (HAS)：企業の財務・戦略的SWOT分析
    Hasbro, Inc. (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cinkarna Celje d.d. Celje (CICG)：企業の財務・戦略的SWOT分析
    Cinkarna Celje d.d. Celje (CICG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Nuvo Pharmaceuticals Inc (NRI)：企業の財務・戦略的SWOT分析
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver dr …
  • E-CO Energi Holding AS：企業の戦略的SWOT分析
    E-CO Energi Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Statnett SF：企業の戦略的SWOT分析
    Statnett SF - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • curasan AG (CUR)：企業の製品パイプライン分析2018
    Summary curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, ora …
  • ALK-Abello AS (ALK B)：製薬・医療：M&Aディール及び事業提携情報
    Summary ALK-Abello AS (ALK), a subsidiary of The Lundbeck Foundation discovers, develops and commercializes immunotherapies for allergy prevention and treatment. It markets diagnostics and other services to allergy clinics. The company's allergy immunotherapy product portfolio includes tablet-based …
  • Asiana Airlines Inc.：企業の戦略・SWOT・財務分析
    Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report Summary Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hsh Nordbank Private Banking
    Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Minnetronix Inc：医療機器：M&Aディール及び事業提携情報
    Summary Minnetronix Inc (Minnetronix) is a medical device company that offers medical system integrators. The company designs electronic and electromechanical systems. It offers products such as intraperitoneal heating and fluids control, brain stimulation system, 3-D imaging for ear canal measureme …
  • Reata Pharmaceuticals Inc (RETA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆